Take a simple test to detect prostate cancer early
and increase successful treatment outcomes.
This Prostate Cancer Risk Assessment is designed for men who have seen a physician regarding
their prostate health. It is based on the likelihood of diagnosing prostate cancer in approximately 2,000 men who have undergone prostate biopsy at Cleveland Clinic.
You will need to know a few common test results, like your PSA level, in order to
complete this risk assessment. If you need clarification on the question being asked,
click the icon to the right of each question for a detailed description.
Have you ever had a biopsy of your prostate?
Probability of having any prostate cancer: ---
Probability of having high grade prostate cancer (Gleason
score sum >=7): ---
This assessment is based on our experience of treating approximately 2,000 prostate cancer patients. This assessment is not a substitute for a second opinion. If you would like to make an appointment with a prostate cancer specialist in our Glickman Urological & Kidney Institute, please call 800.223.2273 ext. 45600 or request an appointment online.
Disclaimer: Please note that we cannot provide treatment recommendations
or diagnose your condition. This Prostate Cancer Risk Assessment Tool is NOT intended
to replace the medical advice, treatment or diagnosis of your physician or health
care provider. Please consult your health care provider for advice about a specific
medical condition. This Prostate Cancer Risk Assessment Tool must be considered
at all times as an educational, convenience service only and shall not be relied
upon nor designed to replace or substitute a physician's independent judgment about
the appropriateness or risks of a procedure for a given patient. Cleveland Clinic
does not endorse, guarantee the accuracy, adequacy, completeness or availability
of any information and is not responsible for any errors or omissions or for the
results obtained from the use of this service. Cleveland Clinic does not guarantee
the availability or ability to use this service.
1 Moussa, A. S., Jones, J. S., Yu, C., Fareed, K., & Kattan, M. W.. Development and validation of a nomogram for predicting a positive repeat prostate biopsy in patients with a previous negative biopsy session in the era of extended prostate sampling. BJU international (April 2010).
2 Development Of An Improved Nomogram For Prediction Of The Outcome Of The Initial Prostate Biopsy Based On Readily Available Clinical Information Osama M. Zaytoun 1 , Michael W. Kattan 2 , Ayman S. Moussa 1 , Jianbo Li 2 , and J. Stephen Jones 1 . Urology (June 2011)